DCPH - Deciphera Pharmaceuticals Inc. (DCPH) CEO Steve Hoerter on Q4 2021 Results - Earnings Call Transcript
Deciphera Pharmaceuticals, Inc. (DCPH) Q4 2021 Earnings Conference Call February 08, 2022, 04:30 PM ET Company Participants Maghan Meyers - SVP, Argot Partners Steve Hoerter - President and CEO Dan Martin - Chief Commercial Officer Tucker Kelly - CFO Conference Call Participants Jessica Fye - JPMorgan Eun Yang - Jefferies Allison Bratzel - Piper Sandler Paul Jeng - Guggenheim Peter Lawson - Barclays Reni Benjamin - JMP Securities Presentation Operator Good afternoon, everyone, and welcome to the Deciphera Pharmaceuticals' Fourth Quarter Full Year 2021 Financial Results Conference Call. [Operator Instructions] At this time, I would like to turn the call over to Maghan Meyers, Senior Vice President, at Argot Partners. Maghan? Maghan Meyers Thank you, operator. Welcome, and thank you for joining us today to discuss Deciphera's fourth quarter and full year 2021 financial results. I'm Maghan Meyers with Argot Partners. With me this afternoon to discuss the financial results
For further details see:
Deciphera Pharmaceuticals, Inc. (DCPH) CEO Steve Hoerter on Q4 2021 Results - Earnings Call Transcript